Upload
jeremy-barrett
View
213
Download
0
Embed Size (px)
Citation preview
Health Technology Entrepreneurship Commercialization Consultants
Technology Development
Contents
2
3
4
About Health TECC
Health TECC’s Clients
The Application Process
Health TECC advises early-stage healthcare
focused companiesThe Healthcare Consulting and Entrepreneurship Program (HCEP),
now known as Health TECC, was established at Boston University in 1996. Health TECC’s mission is to support entrepreneurship in health
care, focusing on businesses in the incubation and start-up phase. Health TECC specializes in pharmaceuticals, biotechnology, medical
device, and other healthcare technology including health IT.
The combination of business, engineering, scientific and medical
expertise represented by the grad student members of the group is at the core
of what allows the group to provide outstanding and
timely help.
Michael Koeris, Novophage CEO
History
TECC was founded in 2011 when consultants from the HCEP became affiliated with the Office of Technology and Development (OTD) and merged with IPconnectED, a student group focused on intellectual property. Health TECC is now the exclusive student group affiliated with OTD in providing healthcare-focused consulting services.
The Health TECC experience
Health TECC members are pro-bono consultants specializing in pharmaceuticals, biotechnology, and medical device. Health TECC collaborates with entrepreneurs affiliated with the Office of Technology Development, the Photonics Center, BioSquare, the Fraunhofer USA Center, and the Entrepreneurial Management Institute.
Members
Health TECC members are an interdisciplinary group of graduate students composed of MBA, PhD, and medical students. This year, Health TECC aims to expand its membership to law students.
Services:
Market access
Reimbursement strategy
Health economics
Opportunity assessment
Regulatory considerations
Intellectual property and patent law
Health TECC2
Employers of Past and Current Health
TECC Members:
BearingPoint
Biogen
Biotronic
Boston MedTech Advisors Bridgehead
International Bristol-Myers Squibb’s
biotechnology technical services
division
Campbell Alliance
Cadence Capital
Decision Resources
Electronic Systems Center and Space
and Missile Command Flagship
Ventures
Genzyme
Johns Hopkins Institute for Cell
Engineering
Leerink Swann
McKinsey
The MITRE Corporation
National Cancer Institute Novophage
Palomar Medical Technologies
PricewaterhouseCoopers
PRTM Management Consultants
Sentient Medical Systems
Past Clients
Novophage
Novophage provides biological solutions for industrial biofilms and has recently received $5.75 million in funding. Michael Koeris, the CEO, who served as an HCEP consultant during his PhD candidacy at Boston University, requested HCEP’s consulting services. As advisors, HCEP:
• analyzed potential regulatory pathways for approval of a novel phage-based antimicrobial;
Health TECC3
• appraised the client of the regulatory environment; and
• identified potential collaboratorsfor Novophage.
Good Start Genetics
Good Start Genetics provides the next generation in technology for genetic screening. HCEP contributions included:
• comparing capital financing options for large equipment purchases through financial modeling;
• identifying key opinion leaders; and• formulating recommendations that
suited the business and cash flow needs of the client.
Entra Pharmaceuticals
Entra Pharmaceuticals is a medical device company that focuses on innovative drug delivery technology. HCEP consultants:
• investigated four therapeutic areas and identified a market access strategy; and
• provided a competitive analysis of the medical device industry.
Entra Pharmaceuticals implemented many of HCEP’s recommendations, including a strategy for new productdevelopment.
Companion Diagnostics
A client with a start-up specializing in companion diagnostics approached HealthTECC, who:
• conducted primary research with prominent pathologists and oncologists to facilitate market adoption;
• performed a thorough analysis of the regulatory pathway for medical diagnostics;
• developed economic models to compare potential business structures; and
• evaluated the advantages and disadvantages in bringing the product to market as a companion diagnostic.
Medical Device
A client who developed a product for the early detection of autism utilized HealthTECC to:
• conduct primary research to evaluate factors surrounding market adoption from customer and consumer perspectives; qualified the current reimbursement landscape; quantified the value-added, which was used for value-based pricing; and
• examined HIPAA issues the client would likely encounter due to the use of HIT.
Areas of Expertise:
Anti-Infectives Child Development
Companion Diagnostics Genetic Screening
Neurology Oncology
Personalized Medicine
Health TECC will accept applications from:
The School of Management The College of Engineering The Law SchoolBoston Medical Center
What To Expect
• Confirmation upon receipt of application• Application deadline: Wednesday October
16, 2013• Notification of interview selection by:
Sunday October 20, 2013• Interview date: Tuesday October 22, 2013• New consultants announced by: Sunday
October 27, 2013• New member introduction at first general
meeting: Wednesday October 30, 2013
Health TECC4
Managing Directors
Cory Peterson, MBA CandidateSalwa Masud, MS Candidate, BME
http://www.bu.edu/otd/education/tecc-student-consultants/
Facebook: Technology Entrepreneurship and Commercialization Consultants (TECC)
Email inquiries:[email protected]